RecruitingNot ApplicableNCT06353672

A Study to Evaluate Safety and Feasibility of Robotic Liver Resection


Sponsor

Zhejiang University

Enrollment

1,000 participants

Start Date

Dec 1, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

The robotic surgery system, the most advanced technology in minimally invasive surgery, overcame some shortcomings of laparoscopic surgery and improved the flexibility and precision of liver resection. Several studies have demonstrated that the robotic system was safe and feasible in liver surgery and might be advantageous in complex hepatic vein and hilar dissection, operative bleeding control, and biliary reconstruction. Previous comparative studies found limited evidence for significantly improved outcomes in robotic liver resection (RLR) over laparoscopic liver resection (LLR) or open liver resection (OLR), considering the various degrees of difficulty in liver surgeries. This study aimed to evaluate safety and feasibility of robotic liver resection, by comparing it with LLR or OLR, and gain veritable and relevant data on the benefits of RLR.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria2

  • The patients were diagnosed with a liver tumor.
  • The patients underwent robotic liver resection.

Exclusion Criteria1

  • The patients underwent simultaneous malignancy resection of the colorectum or other organs (except gallbladder).

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERobotic liver resection

Liver resection using Da Vinci robotic system


Locations(1)

First Affiliated Hospital, Medical College of Zhejiang University

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06353672


Related Trials